Lung Cancer Clinical Trial
Biology of Young Lung Cancer Study: The YOUNG LUNG Study
Summary
The purpose of this research study is to learn more about lung cancer (NSCLC or SCLC) diagnosed in adults at ages 45 or younger.
Full Description
This research study looks to enroll as many people diagnosed with lung cancer at 45 years old or younger in order to:
Better understand causes of lung cancer in individuals 45 years old and younger, which is a rare disease
Better estimate lung cancer risks and potential risk factors for lung cancer in individuals 45 years old and younger
Examine tumor (somatic) or normal (germline) genetic changes that may be shared among young lung cancer patients
Improve opportunities for screening and treatment of lung cancer in individuals 45 years old and younger
Study procedures will include:
Collecting information from participants' medical record and two (2) short questionnaires
Collecting blood and/or saliva samples
Collecting tumor tissue samples (optional)
It is expected that about 500 people will take part in this research study. Participants will be in this study until it closes or the participant withdraws consent.
Eligibility Criteria
Inclusion Criteria:
Age 45 and under at lung cancer diagnosis
Pathologically confirmed bronchogenic lung carcinoma (NSCLC or SCLC of any stage) at any treatment time point
Provision of written informed consent
Willingness to undergo no more than two (2) peripheral blood draws in a four (4) week period, with no more than 50 ml peripheral blood collected over eight (8) weeks
Individuals under age 18 are eligible for study if they meet defined criteria; in addition, consent for participation must be given by a legal guardian or parent
Exclusion Criteria:
Individuals who decline to sign consent
Individuals who are unable to give consent or assent and are without a designated healthcare proxy
Compromise of patient diagnosis or staging if tissue is used for research
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 2 Locations for this study
Boston Massachusetts, 02114, United States
Boston Massachusetts, 02115, United States
Boston Massachusetts, 02115, United States
Boston Massachusetts, 02115, United States
How clear is this clinincal trial information?